In a major advance for patients with Crohn's disease, a new study led by researchers at Mount Sinai Health System found that guselkumab, a medication with a mechanism of action that is new to inflammatory bowel disease (IBD) ...
Jul 17, 2025
0
0
A new international study led by researchers at McMaster University has identified the most effective and safest treatments for people suffering from chronic urticaria, more commonly known as chronic hives.
Jul 15, 2025
0
0
Chronic liver disease (CLD) is a major global health concern, affecting approximately 1.5 billion people. This life-threatening disease often progresses silently, eventually leading to worsened conditions like liver cirrhosis ...
Jul 28, 2025
0
0
Patients with bronchial asthma suffer from attacks of shortness of breath caused by constricted airways. "Anti-inflammatory medications are usually given to treat this, although it isn't quite clear how inflammation and constriction ...
Jul 29, 2025
0
18
GLP1 agonist drugs, commonly known by brand names such as Ozempic and Mounjaro, reduce asthma symptoms in obese people according to a new study from the University of Aberdeen and the Observational and Pragmatic Research ...
Jul 25, 2025
0
0
Allergic to peanuts? Bees? Pollen? Cockroaches? There's a shot for that.
Jul 30, 2025
0
0
The American Academy of Otolaryngology–Head and Neck Surgery Foundation (AAO-HNSF) published the Clinical Practice Guideline (CPG): Adult Sinusitis Update today in Otolaryngology–Head and Neck Surgery. The purpose of ...
Jul 31, 2025
0
0
High levels of a hormone found in cells in the gut could underlie many cases of chronic diarrhea and help explain up to 40% of cases of patients with irritable bowel syndrome with diarrhea, according to a new study led by ...
Jul 29, 2025
0
0
Chronic kidney disease (CKD) affects millions worldwide and is a major global health issue which is characterized by the gradual loss of kidney function over time, leading to serious health complications. Biomarkers that ...
Aug 12, 2025
0
0
For the first time, people with bronchiectasis will have a treatment option. The U.S. Food and Drug Administration (FDA) has approved Insmed's daily pill brensocatib, which will be sold under the brand name Brinsupri. The ...
Aug 13, 2025
0
0
